Targeting SPAG5 may represent a novel strategy to overcome barriers to current cancer therapies such as metastasis or recurrence after surgery and resistance to standard chemotherapy, endocrine therapy, and targeted therapies. This evidence concerns the gene SPAG5 and cancer.